Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study
This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of this research is to see if the use of the Hugo platform is consistent, accurate, cost effective, and time efficient, as it collects and transmits important real-time health information from other clinics/hospitals, pharmacies, and other electronic devices.
Checked against the public recordLast updated Sep 19, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Mayo Clinic
- Interventions being studied
- Other: Electronic Health Record Review; Other: Medical Device Usage and Evaluation; Other: Survey Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age 18+ * English speaking * Consented for Outcomes Registry Study (15-000136) * Undergoing radiotherapy for cancer treatment with curative intent * Willing to and able to give consent and participate in study * Willing to complete all surveys * Able to access a device (computer, smartphone, or tablet) with web access every day to complete study surveys * Willing to connect to a device (i.e., a smartphone, Fitbit, or tablet) that can regularly link to Hugo for data transfer * Willing to share personal information to Tremendous to be able to obtain the Visa e-cards for time and effort put into this study * Willing to use the Hugo health data sharing platform * Willing to create a Mayo Clinic Patient Portal (if not already created) Exclusion Criteria: * Unable to give consent and enroll prior to administration of baseline survey * Partial breast radiation therapy (RT) (3 fraction), due to overlap in cadence used for all disease sites * Stereotactic body radiation therapy (SBRT) to the lung, due to overlap in cadence used for all disease sites * Co-enrollment on another PRO related study (soft rule) * Coordinator would need to get source data from Adam via Hugo * Response data will only be accessible by select people
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mayo Clinic in RochesterRochester, Minnesota
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 19, 2024. Always confirm current availability with the study team.